NGL Fine-Chem credit ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023


108	108	73.2	32.4	30.5
64.1	64.1	7.6	−22.9	−22.0
0.33×	0.33×	0.26×	0.12×	0.14×
0.19×	0.19×	0.03×	−0.09×	−0.10×
1.49×	1.49×	2.16×	0.61×	0.89×
0.76×	0.88×	0.23×	−0.43×	−0.64×
11.89×	11.89×	9.18×	31.11×	19.24×
24.8%	24.8%	20.6%	11.0%	12.0%
—	0.37×	—	—	—
—	0.03×	—	—	—
—	13.41×	—	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NGLFINE₹2,612.80

NGL Fine-Chem Limited

· Pharma & Health

₹ CrorePeersSYNCOMF JAGSNPHARM HESTERBIOAMRUTANJAN WINDLAS INDOCO SAIPARENTMcap ₹1,614 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Total Debt	30.5	32.4	73.2	108.4	108.4
Net Debt	-22.0	-22.9	7.6	64.1	64.1
Total Debt/Equity	0.14	0.12	0.26	0.33	0.33
Net Debt/Equity	-0.10	-0.09	0.03	0.19	0.19
Total Debt/EBITDA	0.89	0.61	2.16	1.49	1.49
Net Debt/EBITDA	-0.64	-0.43	0.23	0.88	0.76
Interest Coverage (EBIT/Interest)	19.24	31.11	9.18	11.89	11.89
Total Debt/Total Capital %	12.05	10.99	20.57	24.77	24.77
As Filed — company-reported covenants
Debt/Equity (as filed)	—	—	—	0.37	—
Debt Service Coverage (as filed)	—	—	—	0.03	—
Interest Service Coverage (as filed)	—	—	—	13.41	—

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.